Highly infiltrative brain tumours show reduced chemosensitivity associated with a stem cell‐like phenotype-Reference-Cited by-同舟云学术

Highly infiltrative brain tumours show reduced chemosensitivity associated with a stem cell‐like phenotype

Published:2009-06-30 Issue:4 Volume:35 Page:380-393
ISSN:0305-1846
Container-title:Neuropathology and Applied Neurobiology
language:en
Short-container-title:Neuropathology and Applied Neurobiology

Author:

Johannessen T.‐C. A.¹,Wang J.¹,Skaftnesmo K.‐O.¹,Sakariassen P. Ø.¹,Enger P. Ø.¹²,Petersen K.³,Øyan A. M.⁴⁵,Kalland K.‐H.⁴⁵,Bjerkvig R.¹⁶,Tysnes B. B.¹

Affiliation:

1. NorLux Neuro Oncology, Department of Biomedicine,

2. Neurosurgery and

3. Bergen Center for Computational Science, Unifob A/S,

4. The Gade Institute, University of Bergen, Departments of

5. Microbiology and Immunology, Haukeland University Hospital, Bergen, Norway, and

6. NorLux Neuro‐Oncology, Centre Recherché de Public Santé, Luxembourg

Publisher

Wiley

Subject

Physiology (medical),Neurology (clinical),Neurology,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2990.2009.01008.x

Reference94 articles.

1. Tumour stem cells and drug resistance

2. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

3. Chemotherapy resistance of glioblastoma stem cells

4. Stem cells, cancer, and cancer stem cells

5. Cancer Stem Cells: An Old Idea—A Paradigm Shift

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma;Nature Communications;2022-12-06

2. Musashi–1—A Stemness RBP for Cancer Therapy?;Biology;2021-05-05

3. A tumorsphere model of glioblastoma multiforme with intratumoral heterogeneity for quantitative analysis of cellular migration and drug response;Experimental Cell Research;2019-06

4. Blocking distinct interactions between Glioblastoma cells and their tissue microenvironment: A novel multi-targeted therapeutic approach;Scientific Reports;2018-04-03

5. Co-expression of TIMP-1 and its cell surface binding partner CD63 in glioblastomas;BMC Cancer;2018-03-09